FIELD: medicine.
SUBSTANCE: invention relates to medicine, the field of experimental pharmacology. A method for correcting osteoporosis and osteoporotic fractures in the experiment includes modeling osteoporosis using bilateral oophorectomy and osteoporotic fractures of the femur in female Wistar rats. As a means of correction, the compound 2-ethyl-6-methyl-3-hydroxypyridinium hydroxybutanedioate is used at a dose of 2 mg/kg, which is administered daily intragastrically to a laboratory animal once a day, against the background of modeling osteoporosis for eight weeks, and for fractures - against the background of modeling osteoporosis for twelve weeks.
EFFECT: invention provides effective prevention of a drop in the level of microcirculation in the proximal femoral metaphysis, slowing down the development of osteoporosis in a hypoestrogenic state, creating favorable conditions for successful consolidation of fractures.
1 cl, 1 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING EXPERIMENTALOSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND ENALAPRIL | 2013 |
|
RU2542424C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH COMBINATION OF L-NORVALIN AND ROSUVASTATIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540927C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH L-NORVALIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540926C1 |
METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
METHOD FOR RECOMBINANT ERYTHROIETIN CORRECTION OF BONE TISSUE MICROCIRCULATION ACCOMPANYING SIMULATED OSTEOPOROSIS AND ASSOCIATED FRACTURES | 2013 |
|
RU2541181C1 |
METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
Authors
Dates
2022-06-30—Published
2021-12-15—Filed